Institut de cancérologie Strasbourg Europe (ICANS)

Strasbourg, Alsace 67033

1 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Neoplasm Metastasis, Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Recruiting now
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling